Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6

CD6 has recently been identified and validated as risk gene for multiple sclerosis (MS), based on the association of a single nucleotide polymorphism (SNP), rs17824933, located in intron 1. CD6 is a cell surface scavenger receptor involved in T-cell activation and proliferation, as well as in thymoc...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 4; p. e62376
Main Authors Swaminathan, Bhairavi, Cuapio, Angélica, Alloza, Iraide, Matesanz, Fuencisla, Alcina, Antonio, García-Barcina, Maria, Fedetz, Maria, Fernández, Óscar, Lucas, Miguel, Órpez, Teresa, Pinto-Medel, Mª Jesus, Otaegui, David, Olascoaga, Javier, Urcelay, Elena, Ortiz, Miguel A., Arroyo, Rafael, Oksenberg, Jorge R., Antigüedad, Alfredo, Tolosa, Eva, Vandenbroeck, Koen
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 24.04.2013
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:CD6 has recently been identified and validated as risk gene for multiple sclerosis (MS), based on the association of a single nucleotide polymorphism (SNP), rs17824933, located in intron 1. CD6 is a cell surface scavenger receptor involved in T-cell activation and proliferation, as well as in thymocyte differentiation. In this study, we performed a haptag SNP screen of the CD6 gene locus using a total of thirteen tagging SNPs, of which three were non-synonymous SNPs, and replicated the recently reported GWAS SNP rs650258 in a Spanish-Basque collection of 814 controls and 823 cases. Validation of the six most strongly associated SNPs was performed in an independent collection of 2265 MS patients and 2600 healthy controls. We identified association of haplotypes composed of two non-synonymous SNPs [rs11230563 (R225W) and rs2074225 (A257V)] in the 2(nd) SRCR domain with susceptibility to MS (P max(T) permutation = 1×10(-4)). The effect of these haplotypes on CD6 surface expression and cytokine secretion was also tested. The analysis showed significantly different CD6 expression patterns in the distinct cell subsets, i.e. - CD4(+) naïve cells, P = 0.0001; CD8(+) naïve cells, P<0.0001; CD4(+) and CD8(+) central memory cells, P = 0.01 and 0.05, respectively; and natural killer T (NKT) cells, P = 0.02; with the protective haplotype (RA) showing higher expression of CD6. However, no significant changes were observed in natural killer (NK) cells, effector memory and terminally differentiated effector memory T cells. Our findings reveal that this new MS-associated CD6 risk haplotype significantly modifies expression of CD6 on CD4(+) and CD8(+) T cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: BS AC ET A. Antigüedad KV. Performed the experiments: BS AC FM A. Alcina JRO MF TÓ DO EU MAO. Analyzed the data: BS AC IA ET KV. Contributed reagents/materials/analysis tools: MGB IA ÓF ML JO MJPM JRO A. Antigüedad RA. Wrote the paper: BS ET FM EU JRO KV.
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0062376